» Authors » Chien-Wei Huang

Chien-Wei Huang

Explore the profile of Chien-Wei Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 372
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Zeng Y, Huang C, Chen C, Kuo H, Tseng K, et al.
J Formos Med Assoc . 2025 Mar; PMID: 40023754
Purpose: This study investigated whether Fibrosis-4 (FIB-4) score and its change can serve as predictors of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C (CHC) infection receiving direct-acting...
2.
Chen Y, Tsai P, Huang C, Chen C, Hung C, Chen C, et al.
J Formos Med Assoc . 2025 Feb; PMID: 39919992
Background/purpose: The risk of hepatocellular carcinoma (HCC) is increased in patients with chronic hepatitis C (CHC) and elevated alanine transaminase (ALT) levels. The association between HCC and ALT levels after...
3.
Lee S, Yang S, Tsai P, Huang C, Chen C, Hung C, et al.
Clin Mol Hepatol . 2025 Feb; PMID: 39905837
Background & Aims: The survival benefit of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection in patients with hepatocellular carcinoma (HCC), particularly in BCLC stages B/C, remains largely...
4.
Huang C, Huang T, Yang Y, Chang MBBS L, Tu Y, Wu V, et al.
J Am Heart Assoc . 2025 Feb; 14(3):e038714. PMID: 39895534
Background: The object of this study was to investigate the incidence rate of major adverse cardiovascular event (MACE) among patients with primary aldosteronism (PA) after adrenalectomy or mineralocorticoid receptor antagonist...
5.
Yang P, Huang C, Karmakar R, Mukundan A, Chen T, Chou C, et al.
Bioengineering (Basel) . 2025 Jan; 12(1). PMID: 39851364
Early detection of early-stage esophageal cancer (ECA) is crucial for timely intervention and improved treatment outcomes. Hyperspectral imaging (HSI) and artificial intelligence (AI) technologies offer promising avenues for enhancing diagnostic...
6.
Wang S, Wang S, Huang C, Chang T, Chang T, Lo C, et al.
Kaohsiung J Med Sci . 2025 Jan; 41(2):e12929. PMID: 39829106
An 8-week regimen of glecaprevir/pibrentasvir is recommended for treatment-naïve patients with chronic hepatitis C (CHC). In alignment with the Taiwanese government's objective to eliminate hepatitis C by 2025, this study...
7.
Chen Y, Karmakar R, Mukundan A, Huang C, Weng W, Wang H
J Cancer . 2025 Jan; 16(2):470-478. PMID: 39744490
Band selection is a common approach to reduce the data dimensionality of hyperspectral imagery. It extracts several bands of importance in some sense by taking advantage of high spectral correlation....
8.
Huang H, Huang C, Chen Y, Shih H, Cheng W, Liu C, et al.
Micromachines (Basel) . 2024 Aug; 15(8). PMID: 39203597
A novel five-surface phosphor-in-glass (FS-PiG) structure for high illumination and excellent color uniformity in large-view scale LEDs for sensor light source application is demonstrated. YAG phosphor (YAlO:Ce) was uniformly mixed...
9.
Jang T, Huang C, Chang T, Yang C, Lo C, Hung C, et al.
J Formos Med Assoc . 2024 Aug; PMID: 39168745
Background/aims: Hepatitis C virus (HCV) eradication using antiviral agents augments the metabolic profile. Changes in glycated hemoglobin (HbA1c) levels in chronic hepatitis C patients who receive glecaprevir/pibrentasvir (GLE/PIB) remain elusive....
10.
Huang C, Wen C, Chen P, Yong S, Chen J, Li C
Pharmacol Res . 2024 Jul; 207:107320. PMID: 39032837
No abstract available.